Edwards Lifesciences Corporation
NYSE:EW
66.81 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,004.8 | 5,382.4 | 5,232.5 | 4,386.3 | 4,348 | 3,722.8 | 3,435.3 | 2,963.7 | 2,493.7 | 2,322.9 | 2,045.5 | 1,899.6 | 1,678.6 | 1,447 | 1,321.4 | 1,237.7 | 1,091.1 | 1,037 | 997.9 | 931.5 | 860.5 | 704 | 692 | 804 | 905 |
| Cost of Revenue
| 1,379.8 | 1,080.4 | 1,248.9 | 1,080.6 | 1,114.4 | 939.4 | 875.3 | 797.4 | 617.2 | 625.6 | 522.4 | 494.6 | 489.8 | 408.3 | 399.1 | 419.6 | 378.2 | 373.6 | 374.6 | 370.2 | 359.4 | 299.1 | 324 | 423 | 466 |
| Gross Profit
| 4,625 | 4,302 | 3,983.6 | 3,305.7 | 3,233.6 | 2,783.4 | 2,560 | 2,166.3 | 1,876.5 | 1,697.3 | 1,523.1 | 1,405 | 1,188.8 | 1,038.7 | 922.3 | 818.1 | 712.9 | 663.4 | 623.3 | 561.3 | 501.1 | 404.9 | 368 | 381 | 439 |
| Gross Profit Ratio
| 0.77 | 0.799 | 0.761 | 0.754 | 0.744 | 0.748 | 0.745 | 0.731 | 0.752 | 0.731 | 0.745 | 0.74 | 0.708 | 0.718 | 0.698 | 0.661 | 0.653 | 0.64 | 0.625 | 0.603 | 0.582 | 0.575 | 0.532 | 0.474 | 0.485 |
| Reseach & Development Expenses
| 1,071.8 | 945.2 | 903.1 | 760.7 | 752.7 | 622.2 | 552.6 | 443.3 | 383.1 | 346.5 | 323 | 291.3 | 246.3 | 204.4 | 175.5 | 139.2 | 122.3 | 114.2 | 99 | 87 | 72.8 | 65.2 | 55 | 55 | 55 |
| General & Administrative Expenses
| 1,823.4 | 1,566.5 | 1,494 | 0 | 0 | 1,088.5 | 984.7 | 904.7 | 850.7 | 858 | 745.6 | 705.3 | 642.4 | 550 | 508.8 | 480.6 | 418 | 376 | 348.7 | 319.9 | 289.9 | 227.9 | 203 | 216 | 233 |
| Selling & Marketing Expenses
| 0 | 1.1 | -0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,823.4 | 1,567.6 | 1,493.7 | 1,228.4 | 1,242.2 | 1,088.5 | 984.7 | 904.7 | 850.7 | 858 | 745.6 | 705.3 | 642.4 | 550 | 508.8 | 480.6 | 418 | 376 | 348.7 | 319.9 | 289.9 | 227.9 | 203 | 216 | 233 |
| Other Expenses
| 3.4 | 2.6 | 12.7 | 11.5 | 8.2 | 4 | -8.2 | -4.9 | -4 | -7.7 | -1.3 | -1.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 59.7 | 86 | 15 | 34 |
| Operating Expenses
| 2,895.2 | 2,512.8 | 2,396.8 | 1,989.1 | 1,994.9 | 1,710.7 | 1,537.3 | 1,348 | 1,233.8 | 1,204.5 | 1,068.6 | 996.6 | 888.7 | 754.4 | 684.3 | 643.8 | 540.3 | 490.2 | 447.7 | 406.9 | 362.7 | 352.8 | 344 | 286 | 322 |
| Operating Income
| 1,534.1 | 1,748.5 | 1,348.5 | 1,628.4 | 1,146.8 | 748.2 | 1,022.7 | 783.8 | 642.7 | 482.6 | 454.5 | 408.4 | 300.1 | 284.3 | 238 | 198.3 | 172.6 | 173.2 | 175.6 | 154.4 | 138.4 | 52.1 | 24 | 95 | 117 |
| Operating Income Ratio
| 0.255 | 0.325 | 0.258 | 0.371 | 0.264 | 0.201 | 0.298 | 0.264 | 0.258 | 0.208 | 0.222 | 0.215 | 0.179 | 0.196 | 0.18 | 0.16 | 0.158 | 0.167 | 0.176 | 0.166 | 0.161 | 0.074 | 0.035 | 0.118 | 0.129 |
| Total Other Income Expenses Net
| -181.3 | 18.9 | 353.5 | -711.7 | 19.7 | -313.4 | 15.1 | -72 | -11 | 662 | 66 | -17.7 | -16.8 | -14.6 | 67.5 | -32.8 | -21.4 | 1.8 | -49.2 | -110.1 | -32.4 | -44.3 | -77 | -320 | 4 |
| Income Before Tax
| 1,598.1 | 1,767.4 | 1,702 | 916.7 | 1,166.5 | 761.4 | 1,034.9 | 737.9 | 622.4 | 1,144 | 515.3 | 391.1 | 283.6 | 268.2 | 304.4 | 164.4 | 149.8 | 172.3 | 116.7 | 30.1 | 92.8 | 56 | -9 | -259 | 113 |
| Income Before Tax Ratio
| 0.266 | 0.328 | 0.325 | 0.209 | 0.268 | 0.205 | 0.301 | 0.249 | 0.25 | 0.492 | 0.252 | 0.206 | 0.169 | 0.185 | 0.23 | 0.133 | 0.137 | 0.166 | 0.117 | 0.032 | 0.108 | 0.08 | -0.013 | -0.322 | 0.125 |
| Income Tax Expense
| 198.7 | 245.5 | 198.9 | 93.3 | 119.6 | 39.2 | 412.8 | 168.4 | 127.5 | 332.9 | 123.6 | 97.9 | 46.9 | 50.2 | 75.3 | 35.5 | 36.8 | 41.8 | 37.4 | 28.4 | 13.8 | 0.3 | 1 | 13 | 31 |
| Net Income
| 1,402.4 | 1,521.9 | 1,503.1 | 823.4 | 1,046.9 | 722.2 | 622.1 | 569.5 | 494.9 | 811.1 | 391.7 | 293.2 | 236.7 | 218 | 229.1 | 128.9 | 113 | 130.5 | 79.3 | 1.7 | 79 | 55.7 | -12 | -272 | 82 |
| Net Income Ratio
| 0.234 | 0.283 | 0.287 | 0.188 | 0.241 | 0.194 | 0.181 | 0.192 | 0.198 | 0.349 | 0.191 | 0.154 | 0.141 | 0.151 | 0.173 | 0.104 | 0.104 | 0.126 | 0.079 | 0.002 | 0.092 | 0.079 | -0.017 | -0.338 | 0.091 |
| EPS
| 2.31 | 2.46 | 2.41 | 1.32 | 1.68 | 1.15 | 0.98 | 0.89 | 0.77 | 1.27 | 0.59 | 0.43 | 0.35 | 0.32 | 0.34 | 0.19 | 0.16 | 0.19 | 0.11 | 0.003 | 0.11 | 0.078 | -0.017 | -0.39 | 0.12 |
| EPS Diluted
| 2.3 | 2.44 | 2.38 | 1.3 | 1.64 | 1.13 | 0.96 | 0.87 | 0.75 | 1.25 | 0.57 | 0.41 | 0.33 | 0.31 | 0.33 | 0.18 | 0.16 | 0.18 | 0.11 | 0.003 | 0.11 | 0.076 | -0.017 | -0.39 | 0.12 |
| EBITDA
| 1,945.3 | 1,829.9 | 1,483.3 | 1,735.6 | 1,330.6 | 1,390.1 | 999.4 | 885.4 | 649.7 | -176.9 | 387.2 | 424.4 | 316.9 | 298.9 | 238 | 174.3 | 248.8 | 228.2 | 281 | 320.2 | 216.4 | 136.8 | 158 | 489 | 197 |
| EBITDA Ratio
| 0.324 | 0.34 | 0.283 | 0.396 | 0.306 | 0.373 | 0.291 | 0.299 | 0.261 | -0.076 | 0.189 | 0.223 | 0.189 | 0.207 | 0.18 | 0.141 | 0.228 | 0.22 | 0.282 | 0.344 | 0.251 | 0.194 | 0.228 | 0.608 | 0.218 |